Carbamazepine-induced hypogammaglobulinemia
dc.authorid | 0000-0001-6796-9359 | en_US |
dc.authorid | 0000-0001-6745-4849 | |
dc.authorid | 0000-0001-8848-4561 | |
dc.contributor.author | Özaras, Nihal | |
dc.contributor.author | Göksügür, Nadir | |
dc.contributor.author | Eroğlu, Saliha | |
dc.contributor.author | Tabak, Ömür | |
dc.contributor.author | Canbakan, Billur | |
dc.date.accessioned | 2021-06-23T19:33:51Z | |
dc.date.available | 2021-06-23T19:33:51Z | |
dc.date.issued | 2012 | |
dc.department | BAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description.abstract | Carbamazepine is used to control seizures. Its common side effects are sleep disorders, anorexia, nausea, vomiting, polydipsia, irritability, ataxia, and diplopia. Involvement of the immune system is rare, and few cases of decreased immunoglobulin levels have been reported. We describe a patient with low immunoglobulin levels due to carbamazepine use who presented with recurrent urinary tract infection. Intravenous immunoglobulin was administered, and immunoglobulin levels increased to safer levels after discontinuation of carbamazepine. Previous reports describe severe infection after carbamazepine-induced hypogammaglobulinemia. Therefore, in patients using antiepileptics, particularly carbamazepine, serum immunoglobulin levels should be checked in those with recurrent infections. (C) 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved. | en_US |
dc.identifier.doi | 10.1016/j.seizure.2011.12.013 | |
dc.identifier.endpage | 231 | en_US |
dc.identifier.issn | 1059-1311 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 22251925 | en_US |
dc.identifier.scopus | 2-s2.0-84858074385 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 229 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.seizure.2011.12.013 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12491/7236 | |
dc.identifier.volume | 21 | en_US |
dc.identifier.wos | WOS:000302449700018 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | Göksügür, Nadir | |
dc.language.iso | en | en_US |
dc.publisher | W B Saunders Co Ltd | en_US |
dc.relation.ispartof | Seizure-European Journal Of Epilepsy | en_US |
dc.relation.publicationcategory | Olgu Sunumu - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Carbamazepine | en_US |
dc.subject | Hypogammaglobulinemia | en_US |
dc.subject | Infection | en_US |
dc.title | Carbamazepine-induced hypogammaglobulinemia | en_US |
dc.type | Case Report | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- nihal-ozaras.pdf
- Boyut:
- 185.53 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin/Full Text